Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination
NCT01915888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2014-11-17
Summary
This study aims to estimate the clinical and cost impact of Rotarix vaccinations among children aged less than 5 years using insurance claims data from commercial plans and Medicaid low-income population. The impact of incomplete and complete Rotarix vaccination will also be examined, overall and stratified by calendar time of Rotarix vaccination (e.g., 2008 onward).
Conditions
- Infections, Rotavirus
Interventions
- OTHER
-
Data interpretation
The data collected for each group will be fully de-identified, interpreted and analysed separately for the 2 databases (MarketScan Commercial and MarketScan Medicaid).
Sponsors & Collaborators
-
Analysis Group, Inc.
collaborator INDUSTRY - lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2014-02-28
- Completion
- 2014-02-28
More Related Trials
-
To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus
NCT04819412 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
NCT00653198 ·Status: COMPLETED
-
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa
NCT04658914 ·Status: COMPLETED ·Phase: PHASE2
-
ROTATEQ Reexamination Study (V260-037)
NCT01074242 ·Status: COMPLETED
-
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
NCT01236066 ·Status: COMPLETED
-
Developing World Study for RotaTeq™ (V260-015)(COMPLETED)
NCT00362648 ·Status: COMPLETED ·Phase: PHASE3
-
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
NCT00329745 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis
NCT01733862 ·Status: COMPLETED
-
Phase Three Clinical Trials of Trivalent Rotavirus Genetic Reassortment Vaccine
NCT01738074 ·Status: UNKNOWN ·Phase: PHASE3
-
Improving Rotavirus Vaccine Immune Response
NCT01825109 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old
NCT06350058 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
NCT01339221 ·Status: COMPLETED
-
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
NCT01575197 ·Status: COMPLETED ·Phase: PHASE4
-
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
NCT01026779 ·Status: COMPLETED
-
Effectiveness of Monovalent Rotavirus Vaccine (RV1)
NCT01871038 ·Status: COMPLETED
-
Study to Evaluate the Safety of Rotarix™ in Chinese Children
NCT01086436 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis
NCT01978223 ·Status: WITHDRAWN
-
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
NCT01563159 ·Status: COMPLETED
-
Phase III Study of Liquid Formulation of ROTAVIN
NCT03703336 ·Status: COMPLETED ·Phase: PHASE3
-
Reactogenicity, Safety and Immunological Efficacy of the Live, Pentavalent Rotavirus Vaccine in Childhood Immunization
NCT05032391 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Rotavirus Immunization in Nicaragua
NCT01133808 ·Status: COMPLETED
-
Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.
NCT02534935 ·Status: COMPLETED ·Phase: PHASE2
-
Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™
NCT01511133 ·Status: COMPLETED
-
Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
NCT01266850 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 ·Status: COMPLETED